FRAZIANO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 20.609
EU - Europa 2.596
AS - Asia 2.373
SA - Sud America 416
AF - Africa 97
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 26.130
Nazione #
US - Stati Uniti d'America 20.513
SG - Singapore 983
IT - Italia 527
CN - Cina 414
DE - Germania 414
BR - Brasile 329
UA - Ucraina 273
IE - Irlanda 246
HK - Hong Kong 195
GB - Regno Unito 193
RU - Federazione Russa 193
FR - Francia 175
SE - Svezia 152
SA - Arabia Saudita 141
PL - Polonia 139
VN - Vietnam 117
KR - Corea 89
FI - Finlandia 84
JP - Giappone 82
IN - India 76
CA - Canada 64
NL - Olanda 44
IR - Iran 42
PK - Pakistan 38
AR - Argentina 32
BE - Belgio 31
ID - Indonesia 27
JO - Giordania 27
MX - Messico 26
AU - Australia 25
TR - Turchia 25
ES - Italia 23
ZA - Sudafrica 23
PH - Filippine 22
AT - Austria 20
EG - Egitto 20
BD - Bangladesh 18
IQ - Iraq 17
ET - Etiopia 16
EC - Ecuador 15
CH - Svizzera 14
NG - Nigeria 13
CO - Colombia 12
CZ - Repubblica Ceca 12
LT - Lituania 10
TW - Taiwan 10
CL - Cile 9
PT - Portogallo 9
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
GH - Ghana 6
MY - Malesia 6
EU - Europa 5
IL - Israele 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
TN - Tunisia 5
VE - Venezuela 5
ER - Eritrea 4
GR - Grecia 4
KE - Kenya 4
NO - Norvegia 4
PY - Paraguay 4
BG - Bulgaria 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HU - Ungheria 2
KZ - Kazakistan 2
LI - Liechtenstein 2
LY - Libia 2
MA - Marocco 2
OM - Oman 2
QA - Qatar 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MV - Maldive 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 26.125
Città #
Woodbridge 5.608
Wilmington 4.989
Houston 4.661
Fairfield 642
Singapore 551
Ann Arbor 548
Chandler 499
Ashburn 457
Seattle 260
Jacksonville 243
Dublin 211
Cambridge 190
Beijing 189
Hong Kong 172
Rome 169
Dearborn 164
New York 163
Medford 160
Jeddah 131
Los Angeles 114
Kraków 99
The Dalles 91
Lawrence 76
Santa Clara 73
Dallas 55
Tokyo 48
Munich 46
São Paulo 46
Buffalo 45
Milan 45
Menlo Park 44
Council Bluffs 43
Mülheim 41
Hamburg 40
Hanoi 36
Ho Chi Minh City 33
Boardman 31
Moscow 31
San Diego 31
Warsaw 31
London 28
Amman 27
Seoul 26
Brussels 25
Montreal 25
Philadelphia 25
Nuremberg 22
Helsinki 21
Chicago 20
Atlanta 19
Denver 19
Guangzhou 19
Phoenix 19
Chennai 18
Hefei 18
Jakarta 18
Stockholm 18
Brooklyn 17
Mountain View 17
Toronto 17
Cairo 16
Frankfurt am Main 15
Mexico City 15
Redwood City 15
Johannesburg 14
Minneapolis 14
Poplar 14
Naples 13
Boston 12
Rio de Janeiro 12
Belo Horizonte 11
Birmingham 11
Mumbai 11
Norwalk 11
San Francisco 11
San Jose 11
San Mateo 11
Kunming 10
Lappeenranta 10
Orem 10
Palo Alto 10
Redondo Beach 10
Southampton 10
Central 9
Madrid 9
Manchester 9
Zhengzhou 9
Amsterdam 8
Falls Church 8
Florence 8
Nanjing 8
Oceanside 8
Quezon City 8
Saint Petersburg 8
San Juan 8
Shanghai 8
Vienna 8
Creede 7
Kochi 7
Melbourne 7
Totale 21.938
Nome #
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 641
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 532
B-Pred, a structure based B-cell epitopes prediction server 510
In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures 500
CD4-8- T-cells increase in MRL/lpr mice treated with thymic factors 491
A new Mycobacterium tuberculosis smooth colony reduces growth inside human macrophages and represses PDIM Operon gene expression. Does an heterogeneous population exist in intracellular mycobacteria? 476
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 461
The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanism 451
Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells 449
Monosodium urate crystals promote innate anti-mycobacterial immunity and improve BCG efficacy as a vaccine against tuberculosis 449
Mycobacterium tuberculosis may escape helper T cell recognition by infecting human fibroblasts 449
Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells 447
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 444
In vitro anti Mycobacterium tuberculosis H37Rv activity of Lannea acida A. Rich from Burkina Faso 444
Compartmentalization of the redox environment in PC-12 neuronal cells 438
Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes 438
Diagnosis of tuberculosis: Available technologies, limitations, and possibilities 436
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 435
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 435
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 430
Effective anti-tumor immunity induced in mice by a two-step vaccination protocol 429
PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis 428
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 426
Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis 423
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 420
Asymmetric liposomes and uses in medical field thereof 419
Immunoregulatory compounds 419
Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages 419
Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer 409
Role of macrophage phospholipase D in natural and CpG-induced antimycobacterial activity 405
CpG oligodeoxynucleotides promote phospholipase D dependent phagolysosome maturation and intracellular mycobacterial killing in M. tuberculosis infected type II alveolar epithelial cells 401
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 398
CpG oligodeoxynucleotides induce Ca2+-dependent phospholipase D activity leading to phagolysosome maturation and intracellular mycobacterial growth inhibition in monocytes 394
Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes 394
Mycobacterial 19-kDa lipoprotein mediates Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages at early stages of infection 393
Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection 391
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine 389
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 379
Molecular bases for the anti-HIV-1 effect of NO. Commentary 378
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 377
Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection 373
Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection 372
Nitric oxide inhibits the HIV-1 reverse transcriptase activity 370
Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases 367
Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice 365
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 363
Nitric oxide inhibits HIV-1 replication in human astrocytoma cells 349
Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement 348
Monocytes/macrophages in HIV infection and tuberculosis 337
Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance 337
Analysis of the shotgun expression library of the Mycobacterium tuberculosis genorne for immunodominant polypeptides: Potential use in serodiagnosis 326
Mycobacterium tuberculosis and human macrophage: the bacillus with "environment-sensing" 323
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29 287
Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts 266
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 254
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 220
Hydroalcoholic extract from Origanum vulgare induces a combined anti-mycobacterial and anti-inflammatory response in innate immune cells 219
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 209
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 206
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 204
A method permissive to fixation and permeabilization for the multiparametric analysis of apoptotic and necrotic cell phenotype by flow cytometry 203
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases 197
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy 187
When PINK is a question: A possible evolutionary trade-off in the Galápagos Pink Land Iguana (Conolophus marthae) 173
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 148
Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress 133
25-Hydroxyvitamin D Plasma Levels in Natural Populations of Pigmented and Partially Pigmented Land Iguanas from Galápagos (Conolophus spp.) 120
Rifampicin-liposomes for mycobacterium abscessus infection treatment: intracellular uptake and antibacterial activity evaluation 108
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 104
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 99
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 99
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 97
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 95
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 94
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis 87
Bioactive liposomes for the control of Mycobacterium abscessus infection. 86
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 86
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 85
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 83
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 81
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 70
Immunization with mycobacterium tuberculosisantigens encapsulated in phosphatidylserine liposomes improves protection afforded by BCG 64
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Mycobacterium abscessus: Chitosan or ε-Poly-L-Lysine Decoration 61
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 60
PMN-MDSC frequency discriminates active versus latent tuberculosis and could play a role in counteracting the immune-mediated lung damage in active disease 56
Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance 47
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models 45
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 44
Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages 34
Totale 26.388
Categoria #
all - tutte 62.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.584 0 0 0 0 0 389 453 339 110 96 142 55
2021/2022936 25 64 35 28 17 69 61 165 76 86 59 251
2022/20231.213 97 110 42 153 150 247 92 73 118 4 88 39
2023/20241.309 68 16 19 157 141 357 151 101 69 50 66 114
2024/20252.258 152 383 230 167 107 193 218 106 214 179 168 141
2025/20261.925 330 227 422 411 408 127 0 0 0 0 0 0
Totale 26.388